We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
CMA considers that undertakings offered by aerospace equipment manufacturer Safran could resolve competition concerns relating to its acquisition of part of aerospace business Collins.
Guidance for manufacturers of artificial heart valves. It outlines specific scenarios that should be considered when determining if an incident is reportable.
Market study will assess how the civil engineering sector operates to improve the design, planning and delivery of key infrastructure.
We help people, businesses and the UK economy by promoting competitive markets and tackling unfair behaviour. CMA is a non-ministerial department.
Information for manufacturers of medical devices on post-market surveillance, reporting adverse incidents and field safety corrective actions to the MHRA.
How we assess issues of potential regulatory concern
Guidance covering various aspects of pharmacovigilance for authorised and unauthorised medicinal products (Specials and the Early Access to Medicines Scheme (EAMS)).
Entry into enclosed spaces onboard ships is sometimes a necessary but dangerous work activity. This guidance outlines regulations and provides information and advice on how to identify an enclosed space and how to reduce the risk to life.
Information about medical devices that the public can buy for personal use and how we make sure they are safe and effective.
This is a check-against-delivery text of the speech 'Discourse: The future of engineering biology' delivered by Government Chief Scientific Adviser Professor Dame Angela McLean at The Royal Institution on 25 April 2025.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).